Specific examples of fine-mapped signals include a Crohn's disease risk variant located in the intron of SMAD3 (rs17293632, C>T) that prevents the robust binding of AP-1, which in turn disrupts AP-1 regulation of TGF-β–SMAD3 pathway and highlights a potential mode of action to increase disease risk. Here, SMAD3 is linked to Crohn disease.